About IMS Health Holdings (NYSE:IMS)
IMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company's data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company's principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.
Industry, Sector and Symbol
Industry IT Services & Consulting
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity5.62%
Return on Assets1.22%
Frequently Asked Questions for IMS Health Holdings (NYSE:IMS)
What is IMS Health Holdings' stock symbol?
IMS Health Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMS."
How were IMS Health Holdings' earnings last quarter?
IMS Health Holdings Inc (NYSE:IMS) issued its quarterly earnings results on Wednesday, July, 27th. The information technology services provider reported $0.41 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.38 by $0.03. The information technology services provider earned $802 million during the quarter, compared to analyst estimates of $796.93 million. IMS Health Holdings had a return on equity of 5.62% and a net margin of 2.99%. IMS Health Holdings's revenue for the quarter was up 112.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.37 EPS. View IMS Health Holdings' Earnings History.
Who are some of IMS Health Holdings' key competitors?
Some companies that are related to IMS Health Holdings include CGI Group (GIB), Total System Services (TSS), VeriSign (VRSN), Gartner (IT), CDW Corporation (CDW), Qihoo 360 Technology Co Ltd (QIHU), Akamai Technologies (AKAM), Amdocs Limited (DOX), Jack Henry & Associates (JKHY), GoDaddy (GDDY), F5 Networks (FFIV), Fortinet (FTNT), Black Knight (BKFS), LogMein (LOGM), EPAM Systems (EPAM), Booz Allen Hamilton Holding Corporation (BAH), Informatica LLC (INFA) and Aspen Technology (AZPN).
How do I buy IMS Health Holdings stock?
Shares of IMS Health Holdings can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is IMS Health Holdings' stock price today?
One share of IMS Health Holdings stock can currently be purchased for approximately $31.34.
How big of a company is IMS Health Holdings?
IMS Health Holdings has a market capitalization of $10.33 billion. IMS Health Holdings employs 15,000 workers across the globe.
How can I contact IMS Health Holdings?
IMS Health Holdings' mailing address is 83 Wooster Heights Road, DANBURY, CT 06810, United States. The information technology services provider can be reached via phone at +1-203-4484600.
MarketBeat Community Rating for IMS Health Holdings (IMS)MarketBeat's community ratings are surveys of what our community members think about IMS Health Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Analysts' Consensus Rating for IMS Health Holdings (NYSE:IMS) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus analyst ratings for company stocks using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||0 Sell Ratings, 0 Hold Ratings, 0 Buy Ratings, 0 Strong Buy RatingsNo ratings tracked in the last 12 months.|
|Consensus Rating:||N/A (Score: NaN)|
|Analysts' Consensus Price Target: ||N/A|
Consensus Price Target History for IMS Health Holdings (NYSE:IMS)
Analysts' Ratings History for IMS Health Holdings (NYSE:IMS)
(Data available from 11/23/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|5/12/2016||Wells Fargo & Company||Downgrade||Outperform -> Market Perform||N/A|
|5/4/2016||Topeka Capital Markets||Boost Price Target||Buy||$29.00 -> $30.00||N/A|
|3/24/2016||Piper Jaffray Companies||Reiterated Rating||Overweight||$28.00 -> $32.00||N/A|
|2/23/2016||Leerink Swann||Reiterated Rating||Outperform||N/A|
|2/4/2016||J P Morgan Chase & Co||Lower Price Target||$38.00 -> $32.00||N/A|
|2/4/2016||Barclays PLC||Lower Price Target||Equal Weight||$28.00 -> $26.00||N/A|
|2/2/2016||Deutsche Bank AG||Lower Price Target||Buy||$30.00||N/A|
Earnings History and Estimates Chart for IMS Health Holdings (NYSE:IMS)
Earnings History by Quarter for IMS Health Holdings (NYSE IMS)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|7/27/2016||Q216||$0.38||$0.41||$796.93 million||$802.00 million||View||Listen|
|5/3/2016||Q116||$0.38||$0.42||$749.34 million||$774.00 million||View||N/A|
|2/3/2016||Q415||$0.32||$0.37||$788.75 million||$812.00 million||View||N/A|
|10/29/2015||Q315||$0.32||$0.38||$740.98 million||$735.00 million||View||Listen|
|4/24/2015||Q115||$0.31||$0.38||$626.89 million||$632.00 million||View||N/A|
|2/3/2015||Q414||$0.32||$0.34||$679.82 million||$678.00 million||View||N/A|
|10/24/2014||Q314||$0.33||$0.37||$668.30 million||$656.00 million||View||Listen|
|7/24/2014||Q1||$0.37||$0.39||$654.92 million||$662.00 million||View||N/A|
Earnings Estimates for IMS Health Holdings (NYSE:IMS)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for IMS Health Holdings (NYSE:IMS)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for IMS Health Holdings (NYSE IMS)
Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 90.25%
Insider Trades by Quarter for IMS Health Holdings (NYSE IMS)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/23/2015||Kevin C. Knightly||SVP||Sell||19,231||$28.50||$548,083.50|| |
|11/19/2015||Kevin C. Knightly||SVP||Sell||55,000||$28.37||$1,560,350.00|| |
|5/12/2015||Cpp Investment Board Private H||Major Shareholder||Sell||30,554,584||$26.68||$815,196,301.12|| |
|4/9/2014||Cpp Investment Board Private H||Major Shareholder||Sell||11,990,976||$19.10||$229,027,641.60|| |
|4/9/2014||John G Danhakl||Director||Sell||2,463,899||$20.00||$49,277,980.00|| |
Latest Headlines for IMS Health Holdings (NYSE IMS)
IMS Health Holdings (NYSE IMS) Chart for Thursday, November, 23, 2017